News search
Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
About the CNIC 19 Jan 2024 The ImnovAth project seeks an innovative approach to treat atherosclerosis |
Research 20 Nov 2023 Atherosclerosis, previously believed to be an irreversible progressive disease, can be reversed if risk factors are contolled early enough |
Research 21 Jun 2023 A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals |
Research 28 Mar 2022 A study published in the journal eBiomedicine identifies new biomarkers that predict the presence of subclinical atherosclerosis |
Research 29 Jun 2021 A study published in JACC shows that excess circulating triglyceride concentrations are associated with subclinical atherosclerosis and vascular inflammation in individuals with low-to-moderate cardiovascular risk according to standard scores |
About the CNIC 15 Jun 2021 The team led by Dr Ramiro has identified a target protein for the diagnosis and treatment of vascular pathologies |
About the CNIC 13 Apr 2021 The new insight supports the need to keep both LDL cholesterol and blood pressure low throughout life by healthy diet choices, weight control, exercise, and, when needed, by drug therapy |
Research 15 Feb 2021 Among the modifiable cardiovascular risk factors showing a close association with reduced brain metabolism, the research team found that the most important is hypertension |
Research 2 Dec 2020 Un estudio que se publica en Nature muestra a la proteína mitocondrial ALDH4A1 como un nuevo autoantígeno implicado en los procesos de la aterosclerosis |
- 1 of 3
- next ›